Target Price | $36.56 |
Price | $17.73 |
Potential |
106.24%
register free of charge
|
Number of Estimates | 9 |
9 Analysts have issued a price target Summit Therapeutics PLC Sponsored ADR 2026 .
The average Summit Therapeutics PLC Sponsored ADR target price is $36.56.
This is
106.24%
register free of charge
$44.00
148.24%
register free of charge
$30.00
69.25%
register free of charge
|
|
A rating was issued by 11 analysts: 11 Analysts recommend Summit Therapeutics PLC Sponsored ADR to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Summit Therapeutics PLC Sponsored ADR stock has an average upside potential 2026 of
106.24%
register free of charge
|
Analyst | Rating | Action | Date |
---|---|---|---|
JMP Securities |
Locked
➜
Locked
|
Locked | Jun 02 2025 |
Goldman Sachs |
Locked
➜
Locked
|
Locked | May 02 2025 |
JMP Securities |
Locked
➜
Locked
|
Locked | Apr 28 2025 |
Jefferies |
Locked
➜
Locked
|
Locked | Apr 25 2025 |
Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
Citigroup |
Locked
➜
Locked
|
Locked | Mar 26 2025 |
Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
Analyst Rating | Date |
---|---|
Locked
JMP Securities:
Locked
➜
Locked
|
Jun 02 2025 |
Locked
Goldman Sachs:
Locked
➜
Locked
|
May 02 2025 |
Locked
JMP Securities:
Locked
➜
Locked
|
Apr 28 2025 |
Locked
Jefferies:
Locked
➜
Locked
|
Apr 25 2025 |
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Apr 23 2025 |
Locked
Citigroup:
Locked
➜
Locked
|
Mar 26 2025 |
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Mar 21 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.